{"nct_id":"NCT02436135","title":"Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Adults Receiving Ruxolitinib as Therapy for Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis With Progressive or Relapsed Disease","status":"TERMINATED","status_verified_date":"2020-08","start_date":"2015-06-05","start_date_type":"ACTUAL","primary_completion_date":"2017-11-20","primary_completion_date_type":"ACTUAL","completion_date":"2017-11-20","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GILD"]}